Wells Fargo’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52.7M Sell
806,659
-72,857
-8% -$4.93M 0.01% 984
2026
Q2
$56.3M Sell
879,516
-271,273
-24% -$17.8M 0.01% 967
2026
Q1
$81.9M Sell
1,150,789
-206,900
-15% -$16.3M 0.02% 712
2025
Q4
$111M Sell
1,357,689
-10,278
-0.8% -$801K 0.02% 587
2025
Q3
$103M Buy
1,367,967
+130,666
+11% +$9.7M 0.02% 593
2025
Q2
$91.6M Buy
1,237,301
+43,148
+4% +$3M 0.02% 609
2025
Q1
$96.4M Buy
1,194,153
+29,118
+2% +$2.5M 0.02% 558
2024
Q4
$91.1M Buy
1,165,035
+14,794
+1% +$1.26M 0.02% 564
2024
Q3
$108M Buy
1,150,241
+75,119
+7% +$6.31M 0.02% 513
2024
Q2
$83.8M Buy
1,075,122
+134,671
+14% +$11M 0.02% 565
2024
Q1
$85.5M Sell
940,451
-185,120
-16% -$15.4M 0.02% 551
2023
Q4
$87M Buy
1,125,571
+62,843
+6% +$4.4M 0.02% 520
2023
Q3
$72.3M Buy
1,062,728
+359,773
+51% +$26.2M 0.02% 545
2023
Q2
$57.1M Buy
702,955
+16,584
+2% +$1.32M 0.02% 659
2023
Q1
$56.3M Buy
+686,371
New +$49M 0.02% 650

Other funds holding GEHC

Wells Fargo's GEHC Position: Q3 2026 in Review

Wells Fargo reduced its GE HealthCare (GEHC) stake by 8.3% in Q3 2026, selling an estimated $4.93M and leaving 806,659 shares worth $52.7M. The position accounts for 0.01% of the portfolio, ranked #984.

Wells Fargo first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $111M in Q4 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Wells Fargo held 806,659 shares of GE HealthCare worth $52.7M as of Q3 2026.
  • Wells Fargo sold 72,857 GE HealthCare shares in Q3 2026, an estimated $4.93M.
  • GE HealthCare made up 0.01% of Wells Fargo's portfolio in Q3 2026, its #984 holding.
  • Wells Fargo first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
  • Wells Fargo's GE HealthCare position peaked at $111M in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.